Inmunología, Oftalmología y ORL
Saila
![Foto de Inmunología, Oftalmología y ORL](/img/uploaded/7383705E4165CCC3E1D5745D79764C47.png)
![Foto de Hospital Universitario Son Espases](/img/noimage_org.png)
Hospital Universitario Son Espases
Palma, EspañaHospital Universitario Son Espases-ko ikertzaileekin lankidetzan egindako argitalpenak (31)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease
Frontiers in Immunology, Vol. 14
-
SER recommendations for the treatment of uveitis
Reumatologia Clinica, Vol. 19, Núm. 9, pp. 465-477
2022
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
-
The age again in the eye of the COVID-19 storm: evidence-based decision making
Immunity and Ageing, Vol. 18, Núm. 1
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347
-
Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
2019
-
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
Clinica Chimica Acta, Vol. 488, pp. 135-142
-
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368
2018
-
Primary immunodeficiency diseases in lung disease: Warning signs, diagnosis and management
Respiratory Research, Vol. 19, Núm. 1
2017
-
New insights into the genetic component of non-infectious uveitis through an Immunochip strategy
Journal of Medical Genetics, Vol. 54, Núm. 1, pp. 38-46
2016
-
Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections
Clinical Immunology
-
Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency
Clinical Immunology, Vol. 169, pp. 80-84